Free Trial

Spectrum Brands (SPB 26s; B2 Neg/B/BB Neg) 2Q Earnings (3m ending March)

CONSUMER STAPLES
  • Equities are bid up in US morning on the strong 2Q margins & upgrades to FY24 sales & EBITDA guidance.
  • We are not too positive on the local '26 here - a par call enforced by investors doesn't give as much upside as it once did (BVAL offer side is at €99.6).
  • We'd also caution those eyeing lower cash px $ lines - covenant only requires excess proceeds (net of capex & current debt paydowns) to be used - €425m in the €26's is the cheapest refi for it.
  • Without the par call, longer term fundamentals look weak; the co is still carrying large $1.4b gross debt on its now reduced size - FY24 EBITDA consensus is at $324m (already in line with co's guidance for LDD growth) & FCF is at $75m - those leverage ratios are reflected in current single B ratings.
  • It does have a (long-term) net leverage target of 2-2.5x but that leaves one relying on cash staying on BS - its use of sale proceeds to complete $1b in buybacks despite selling of 1/3 of its business is indic. of debt unfriendly choices on cap. allocation - & on that front how it might avoid covenants through capex is still uncertain.
Earnings from earlier below;

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.